The initiative goal is to support the development and evaluation of innovative approaches to deliver genome editing machinery into somatic cells, with the ultimate goal of accelerating the development of genome editing therapeutics to treat human disease. Funded projects are focusing on a wide array of disease-relevant cell types and testing multiple technologies for delivery to these cell types.